Real-world utilization and safety of ipilimumab plus nivolumab (I+N) in metastatic renal cell carcinoma (mRCC) patients: Results from the Canadian Kidney Cancer Information System (CKCis).Myuran Thana, Lori Wood, Naveen S. Basappa et al.|Journal of Clinical Oncology|2020Cited by 0
Efficacy of tyrosine kinase inhibitors (TKI) after combination ipilimumab plus nivolumab (I/N) in metastatic clear cell renal cell carcinoma (ccmRCC) patients: Results from the Canadian Kidney Cancer Information System (CKCis).Austin Kalirai, Naveen S. Basappa, Isaiah Joy et al.|Journal of Clinical Oncology|2022Cited by 0
Population based assessment of HER-2 and PD-L1 positivity in gastric and gastroesophageal junction adenocarcinomas in a Canadian population.Patrick L. Holland, Stephanie Snow, Phillip Moss et al.|Journal of Clinical Oncology|2024Cited by 0